993 HIGH END-OF-TREATMENT RESPONSE (84%) AFTER 4 WEEKS OF R1626, PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOLLOWED BY A FURTHER 44 WEEKS OF PEGINTERFERON ALFA-2A AND RIBAVIRIN
暂无分享,去创建一个
G. Everson | D. Nelson | M. Shiffman | M. Fried | L. Nyberg | P. Pockros | R. Ghalib | G. Hill | E. Godofsky | S. Harrison | M. Rodríguez-Torres | A. Chan